APO RESEARCH · REPORT
Cell Freezing Media for Cell Therapy
Cell freezing medium is a complete cell freezing media for mammalian cell cultures.
Product & engineering
Understand the product.
Cell freezing medium is a complete cell freezing media for mammalian cell cultures.
Most classic formulations of cell freezing media containing dimethyl sulfoxide (DMSO) as the active freezing agent. However, since it is known that DMSO is a mutagen and carcinogen, DMSO-free formulations are becoming popular for stem cell applications. This is an especially critical consideration for cells being used in translational research or clinical applications. Moreover, media formulations that are manufactured under GMP compliance and have drug-master files registered with government regulatory agencies provide added value for regenerative medicine use.
Selected research
Market Structure
Global Cell Freezing Media for Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Cell freezing medium is a complete cell freezing media for mammalian cell cultures.
Most classic formulations of cell freezing media containing dimethyl sulfoxide (DMSO) as the active freezing agent. However, since it is known that DMSO is a mutagen and carcinogen, DMSO-free formulations are becoming popular for stem cell applications. This is an especially critical consideration for cells being used in translational research or clinical applications. Moreover, media formulations that are manufactured under GMP compliance and have drug-master files registered with government regulatory agencies provide added value for regenerative medicine use.
Market competition is intense. BioLife Solutions, Thermo Fisher Scientific, Merck, GE Healthcare, Zenoaq, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. The Top 5 manufacturers occupied 87.85% of global market share in 2019.
Read the full market overview
This report provides an overview of the global Cell Freezing Media for Cell Therapy market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cell Freezing Media for Cell Therapy and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cell Freezing Media for Cell Therapy sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cell Freezing Media for Cell Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.
Cell Freezing Media for Cell Therapy Segment by Company
BioLife Solutions
Thermo Fisher Scientific
Merck
GE Healthcare
Zenoaq
Cell Freezing Media for Cell Therapy Segment by Type
With FBS
Without FBS
Cell Freezing Media for Cell Therapy Segment by Application
Human Embryonic Stem Cells
CAR-T Cell Therapy
Neural Stem Cell Therapy
Mesenchymal Stem Cell Therapy
Hematopoietic Stem Cell Transplantation
Others
Cell Freezing Media for Cell Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Freezing Media for Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell Freezing Media for Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Freezing Media for Cell Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Cell Freezing Media for Cell Therapy market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Freezing Media for Cell Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cell Freezing Media for Cell Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Cell Freezing Media for Cell Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- With FBS
- Without FBS
Applications
- Human Embryonic Stem Cells
- CAR-T Cell Therapy
- Neural Stem Cell Therapy
- Mesenchymal Stem Cell Therapy
- Hematopoietic Stem Cell Transplantation
- Others
Companies covered
- BioLife Solutions
- Thermo Fisher Scientific
- Merck
- GE Healthcare
- Zenoaq
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Cell Freezing Media for Cell Therapy Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Cell Freezing Media for Cell Therapy Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Cell Freezing Media for Cell Therapy Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Cell Freezing Media for Cell Therapy Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Cell Freezing Media for Cell Therapy Market Dynamics
- 2.1 Cell Freezing Media for Cell Therapy Industry Trends
- 2.2 Cell Freezing Media for Cell Therapy Industry Drivers
- 2.3 Cell Freezing Media for Cell Therapy Industry Opportunities and Challenges
- 2.4 Cell Freezing Media for Cell Therapy Industry Restraints
3 Cell Freezing Media for Cell Therapy Market by Manufacturers
- 3.1 Global Cell Freezing Media for Cell Therapy Revenue by Manufacturers (2021-2026)
- 3.2 Global Cell Freezing Media for Cell Therapy Sales by Manufacturers (2021-2026)
- 3.3 Global Cell Freezing Media for Cell Therapy Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Cell Freezing Media for Cell Therapy Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Cell Freezing Media for Cell Therapy Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Cell Freezing Media for Cell Therapy Manufacturers, Product Type & Application
- 3.7 Global Cell Freezing Media for Cell Therapy Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Cell Freezing Media for Cell Therapy Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Cell Freezing Media for Cell Therapy Players Market Share by Revenue in 2025
- 3.8.3 2025 Cell Freezing Media for Cell Therapy Tier 1, Tier 2, and Tier 3
4 Cell Freezing Media for Cell Therapy Market by Type
- 4.1 Cell Freezing Media for Cell Therapy Type Introduction
- 4.1.1 With FBS
- 4.1.2 Without FBS
- 4.2 Global Cell Freezing Media for Cell Therapy Sales by Type
- 4.2.1 Global Cell Freezing Media for Cell Therapy Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Cell Freezing Media for Cell Therapy Sales by Type (2021-2032)
- 4.2.3 Global Cell Freezing Media for Cell Therapy Sales Market Share by Type (2021-2032)
- 4.3 Global Cell Freezing Media for Cell Therapy Revenue by Type
- 4.3.1 Global Cell Freezing Media for Cell Therapy Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Cell Freezing Media for Cell Therapy Revenue by Type (2021-2032)
- 4.3.3 Global Cell Freezing Media for Cell Therapy Revenue Market Share by Type (2021-2032)
5 Cell Freezing Media for Cell Therapy Market by Application
- 5.1 Cell Freezing Media for Cell Therapy Application Introduction
- 5.1.1 Human Embryonic Stem Cells
- 5.1.2 CAR-T Cell Therapy
- 5.1.3 Neural Stem Cell Therapy
- 5.1.4 Mesenchymal Stem Cell Therapy
- 5.1.5 Hematopoietic Stem Cell Transplantation
- 5.1.6 Others
- 5.2 Global Cell Freezing Media for Cell Therapy Sales by Application
- 5.2.1 Global Cell Freezing Media for Cell Therapy Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Cell Freezing Media for Cell Therapy Sales by Application (2021-2032)
- 5.2.3 Global Cell Freezing Media for Cell Therapy Sales Market Share by Application (2021-2032)
- 5.3 Global Cell Freezing Media for Cell Therapy Revenue by Application
- 5.3.1 Global Cell Freezing Media for Cell Therapy Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Cell Freezing Media for Cell Therapy Revenue by Application (2021-2032)
- 5.3.3 Global Cell Freezing Media for Cell Therapy Revenue Market Share by Application (2021-2032)
6 Global Cell Freezing Media for Cell Therapy Sales by Region
- 6.1 Global Cell Freezing Media for Cell Therapy Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Cell Freezing Media for Cell Therapy Sales by Region (2021-2032)
- 6.2.1 Global Cell Freezing Media for Cell Therapy Sales by Region (2021-2026)
- 6.2.2 Global Cell Freezing Media for Cell Therapy Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Cell Freezing Media for Cell Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Cell Freezing Media for Cell Therapy Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Cell Freezing Media for Cell Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Cell Freezing Media for Cell Therapy Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Cell Freezing Media for Cell Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Cell Freezing Media for Cell Therapy Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Cell Freezing Media for Cell Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Cell Freezing Media for Cell Therapy Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Cell Freezing Media for Cell Therapy Revenue by Region
- 7.1 Global Cell Freezing Media for Cell Therapy Revenue by Region
- 7.1.1 Global Cell Freezing Media for Cell Therapy Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Cell Freezing Media for Cell Therapy Revenue by Region (2021-2026)
- 7.1.3 Global Cell Freezing Media for Cell Therapy Revenue by Region (2027-2032)
- 7.1.4 Global Cell Freezing Media for Cell Therapy Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Cell Freezing Media for Cell Therapy Revenue (2021-2032)
- 7.2.2 North America Cell Freezing Media for Cell Therapy Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Cell Freezing Media for Cell Therapy Revenue (2021-2032)
- 7.3.2 Europe Cell Freezing Media for Cell Therapy Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Cell Freezing Media for Cell Therapy Revenue (2021-2032)
- 7.4.2 Asia-Pacific Cell Freezing Media for Cell Therapy Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Cell Freezing Media for Cell Therapy Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Cell Freezing Media for Cell Therapy Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 BioLife Solutions
- 8.1.1 BioLife Solutions Company Information
- 8.1.2 BioLife Solutions Business Overview
- 8.1.3 BioLife Solutions Cell Freezing Media for Cell Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 BioLife Solutions Cell Freezing Media for Cell Therapy Product Portfolio
- 8.1.5 BioLife Solutions Recent Developments
- 8.2 Thermo Fisher Scientific
- 8.2.1 Thermo Fisher Scientific Company Information
- 8.2.2 Thermo Fisher Scientific Business Overview
- 8.2.3 Thermo Fisher Scientific Cell Freezing Media for Cell Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Thermo Fisher Scientific Cell Freezing Media for Cell Therapy Product Portfolio
- 8.2.5 Thermo Fisher Scientific Recent Developments
- 8.3 Merck
- 8.3.1 Merck Company Information
- 8.3.2 Merck Business Overview
- 8.3.3 Merck Cell Freezing Media for Cell Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Merck Cell Freezing Media for Cell Therapy Product Portfolio
- 8.3.5 Merck Recent Developments
- 8.4 GE Healthcare
- 8.4.1 GE Healthcare Company Information
- 8.4.2 GE Healthcare Business Overview
- 8.4.3 GE Healthcare Cell Freezing Media for Cell Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 GE Healthcare Cell Freezing Media for Cell Therapy Product Portfolio
- 8.4.5 GE Healthcare Recent Developments
- 8.5 Zenoaq
- 8.5.1 Zenoaq Company Information
- 8.5.2 Zenoaq Business Overview
- 8.5.3 Zenoaq Cell Freezing Media for Cell Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Zenoaq Cell Freezing Media for Cell Therapy Product Portfolio
- 8.5.5 Zenoaq Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Cell Freezing Media for Cell Therapy Value Chain Analysis
- 9.1.1 Cell Freezing Media for Cell Therapy Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Cell Freezing Media for Cell Therapy Production Mode & Process
- 9.2 Cell Freezing Media for Cell Therapy Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Cell Freezing Media for Cell Therapy Distributors
- 9.2.3 Cell Freezing Media for Cell Therapy Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst